Sageworth Trust Company of South Dakota’s Meridian Bioscience Inc VIVO Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37	Closed	-$1K	–	261
2022 Q4	$1K	Hold	37	–	–	﹤0.01%	250
2022 Q3	$1K	Sell	37 -32	-46%	-$1.04K	﹤0.01%	242
2022 Q2	$2K	Buy	69 +37	+116%	+$1K	﹤0.01%	418
2022 Q1	$1K	Sell	32 -155	-83%	-$3.69K	﹤0.01%	600
2021 Q4	$4K	Buy	+187	New	+$3.59K	0.01%	575

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sageworth Trust Company of South Dakota's VIVO Position: Q1 2023 in Review

Sageworth Trust Company of South Dakota sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 37 shares — an estimated $1K sold.

Sageworth Trust Company of South Dakota first reported a position in VIVO in Q4 2021 and held it in 5 quarters. The position peaked at $4K in Q4 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Sageworth Trust Company of South Dakota reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Sageworth Trust Company of South Dakota sold 37 Meridian Bioscience Inc shares in Q1 2023, an estimated $1K.
Sageworth Trust Company of South Dakota first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 5 quarters.
Sageworth Trust Company of South Dakota's Meridian Bioscience Inc position peaked at $4K in Q4 2021.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q1 2023, filed 9 May 2023.